|
Volumn 13, Issue 2, 2006, Pages 172-178
|
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer.
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
PROTEIN P53;
TUMOR MARKER;
ADENOCARCINOMA;
ADULT;
AGE;
AGED;
ARTICLE;
BREAST TUMOR;
CANCER STAGING;
CAUSE OF DEATH;
COHORT ANALYSIS;
COMPARATIVE STUDY;
DISEASE FREE SURVIVAL;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
JAPAN;
METABOLISM;
MIDDLE AGED;
MORTALITY;
PREDICTION AND FORECASTING;
PREVALENCE;
PROGNOSIS;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SURVIVAL;
ADENOCARCINOMA;
ADULT;
AGE FACTORS;
AGED;
BREAST NEOPLASMS;
CAUSE OF DEATH;
COHORT STUDIES;
DISEASE-FREE SURVIVAL;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
JAPAN;
MIDDLE AGED;
NEOPLASM STAGING;
PREDICTIVE VALUE OF TESTS;
PREVALENCE;
PROGNOSIS;
RECEPTOR, ERBB-2;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 33746809105
PISSN: 13406868
EISSN: None
Source Type: Journal
DOI: 10.2325/jbcs.13.172 Document Type: Article |
Times cited : (49)
|
References (0)
|